Healthcare -
Biotechnology - NASDAQ - US
$ 31.23
0.872 %
$ 12 B
Market Cap
-3.37
P/E
INCOME STATEMENT
EFFICIENCY
Earnings Waterfall
Moderna, Inc.
| Revenue | 3.24 B |
| Cost Of Revenue | 1.46 B |
| Gross Profit | 1.77 B |
| Operating Expenses | 5.72 B |
| Operating Income | -3.94 B |
| Other Expenses | -384 M |
| Net Income | -3.56 B |
Income Statement
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | |
|---|---|---|---|---|---|---|---|---|---|
| REVENUE | |||||||||
| Revenue | 3 236.0 | 6 848.0 | 19 263.0 | 17 736.0 | 274.5 | 48.0 | 122.5 | 177.0 | 101.5 |
| GROSS PROFIT | |||||||||
| Cost Of Revenue | 1 464.0 | 4 693.0 | 5 416.0 | 2 617.0 | 7.9 | 31.0 | 454.1 | 20.5 | 15.1 |
| Gross Profit | 1 772.0 | 2 155.0 | 13 847.0 | 15 119.0 | 266.6 | 17.0 | (331.6) | 156.4 | 86.4 |
| OPERATING INCOME | |||||||||
| Operating Expenses | 5 717.0 | 6 300.0 | 4 427.0 | 1 823.0 | 1 029.7 | 593.8 | 535.8 | 446.3 | 325.3 |
| Selling, General and Administrative Expenses | 1 174.0 | 1 549.0 | 1 132.0 | 567.0 | 188.3 | 109.6 | 94.3 | 64.7 | 57.5 |
| Research and Development Expenses | 4 543.0 | 4 845.0 | 3 295.0 | 1 991.0 | 1 370.3 | 496.3 | 454.1 | 410.5 | 274.7 |
| Operating Income | (3 945.0) | (4 239.0) | 9 420.0 | 13 296.0 | (763.1) | (545.7) | (413.3) | (269.4) | (223.8) |
| PRE-TAX INCOME | |||||||||
| Interest Income Expense | 0 | 38.0 | 29.0 | 18.0 | 9.9 | 6.6 | 3.1 | 0.1 | 0 |
| Total Other Income | 338.0 | 297.0 | 155.0 | (11.0) | 18.6 | 31.0 | 28.9 | 13.4 | 8.6 |
| Pre-Tax Income | (3 607.0) | (3 942.0) | 9 575.0 | 13 285.0 | (744.5) | (514.7) | (384.4) | (256.0) | (215.2) |
| NET INCOME | |||||||||
| Tax Provision | (46.0) | 772.0 | 1 213.0 | 1 083.0 | 2.6 | (0.7) | 0.3 | 80 K | 1.0 |
| Net Income | (3 561.0) | (4 714.0) | 8 362.0 | 12 202.0 | (747.1) | (514.0) | (384.7) | (255.9) | (216.2) |
| EPS | 9.27 | 12.3 | 21.2 | 30.3 | 1.96 | 1.55 | 4.74 | 0.68 | 0.58 |